ESTRO 38 - Programme Book & Exhibition Guide

POSTER VIEWING Poster viewing 3: Brachytherapy 14:30 - 15:45 | Poster area Chair: T.P. Hellebust (Norway) Chair: A. Gomez-Iturriaga (Spain)

SATURDAY 27 APRIL 2019

> Endorectal HDR brachytherapy boost with MRI guidance for non operative management of rectal cancer R. Engineer (India), A. Saklani, A. D'Souza, A. Baheti, M. Patil, S. Chopra, P. Patil > Predictive factors and patients’ selection for pulsed dose rate brachytherapy boost in anal cancer T. Brahmi (France), A.A. Serre, F. Gassa, F. Lafay, M. Sandt, P. Pommier > Treatment outcomes of HDR brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 T. Tantivatana (Thailand), R. Kanisa > HDR BRT treatment of non-melanoma skin cancer: outcome and feasibility in a retrospective analysis D. Delishaj, I.C. Fumagalli, R. D'Amico, G. Sangalli, F. Declich, C. Frigerio, C.P. Soatti (Italy) > High-dose CT-guided interstitial brachytherapy of liver metastases in oligometastatic patients F. Walter (Germany), S. Gerum, M. Rottler, C. Maihöfer, J. Well, L. Nierer, M. Seidensticker, R. Seidensticker, T. Streitparth, F. Streitparth, J. Ricke, C. Belka, S. Corradini > Custom-made moulds plesiotherapy for non-melanoma skin cancer treatment M.Á. González Ruiz (Spain), J.L. Muñoz García, J. Quirós Rivero > The impact of modern imaging on low dose-rate prostate brachytherapy D. Lamb (New Zealand), L. Greig, G. Russell, J. Nacey, L. Woods > RTOG versus CTCAE score: reporting toxicity of HDR brachytherapy Monotherapy for prostate cancer M. Jolicoeur (Canada), E. Hill > MRI-guided salvage HDR brachytherapy for locally recurrent prostate cancer L. Joseph (Canada), A. Sundaramurthy, A. Berlin, J. Helou, C. Menard, P. Warde, C. Catton, B. Lao, A. Bayley, A. Rink, A. Beiki-Ardakani, P. Chung

PV-0139

PV-0140

PV-0141

PV-0142

PV-0143

PV-0144

PV-0145

PV-0146

PV-0147

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

96